Table 2.
Characteristics of Endometrial Cancers Overall and by Menopausal Status
| Total | Postmenopausal | Premenopausal | |
|---|---|---|---|
| Total | 49 (100.0) | 42 (85.7) | 7 (14.3) |
| Diagnostic Specimen | |||
| Biopsy only* | 2 (4.1) | 2 (4.8) | 0 (0.0) |
| Hysterectomy only† | 11 (22.4) | 8 (19.0) | 3 (42.9) |
| Biopsy and Hysterectomy | 36 (73.5) | 32 (76.2) | 4 (57.1) |
| Pathology Grade | |||
| FIGO Grade 1 | 27 (55.1) | 22 (52.4) | 5 (71.4) |
| FIGO Grade 2 | 14 (28.6) | 12 (28.6) | 2 (28.6) |
| FIGO Grade 3 | 6 (12.2) | 6 (14.3) | 0 (0.0) |
| Missing | 2 (4.1) | 2 (4.8) | 0 (0.0) |
| Pathology Stage | |||
| FIGO Stage IA | 35 (71.4) | 29 (69.1) | 6 (85.7) |
| FIGO Stage IB | 7 (14.3) | 7 (16.7) | 0 (0.0) |
| FIGO Stage IIIA | 1 (2.0) | 1 (2.4) | 0 (0.0) |
| FIGO Stage IIIC1/2 | 3 (6.1) | 2 (4.8) | 1 (14.3) |
| FIGO Stage IVB | 1 (2.0) | 1 (2.4) | 0 (0.0) |
| Missing | 2 (4.1) | 2 (4.8) | 0 (0.0) |
| Histology | |||
| Endometrioid | 40 (81.6) | 33 (78.6) | 7 (100.0) |
| Clear Cell | 2 (4.1) | 2 (4.8) | 0 (0.0) |
| Serous‡ | 3 (6.1) | 3 (7.1) | 0 (0.0) |
| Mixed Endometrioid/Mucinous | 1 (2.0) | 1 (2.4) | 0 (0.0) |
| Carcinosarcoma (MMMT) | 1 (2.0) | 1 (2.4) | 0 (0.0) |
| Missing | 2 (4.1) | 2 (4.8) | 0 (0.0) |
| Myometrial Invasion | |||
| No | 10 (20.4) | 7 (17.5) | 3 (42.9) |
| Yes | 36 (73.5) | 33 (82.5) | 3 (42.9) |
| Missing | 3 (4.1) | 2 (4.8) | 1 (14.3) |
| Tumor Size, Mean ± SD | 3.2 ± 1.6 | 3.3 ± 1.6 | 3.1 ± 1.6 |
*
Of the two cases diagnosed on biopsy only, one woman has not yet undergone surgery
†
Of the cases diagnosed by hysterectomy only, 2 had a normal biopsy and 9 had atypical hyperplasia diagnosed on biopsy
‡
Includes one mixed clear cell and serous
Abbreviations: MMMT, malignant mixed Mullerian tumor; SD, standard deviation